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National Advisory Committee on Drugs (NACD) 
Vision, Mission, Values 
 
Vision 
To provide a national focus for all knowledge related efforts that inform Irish policy in relation to 
drug misuse. 
 
Mission  
The NACD has undertaken to: 
 Support the Government in significantly reducing the health, social and economic 
consequences of drug misuse through the provision of timely data and analysis of 
research; 
 Review its knowledge base, identifying gaps which can be addressed through research; 
 Ensure that evidence from scientific research forms the basis for policy formulation, 
development of services and continuous improvement in all its approaches to tackling 
drug misuse in Ireland;  
 Work closely with the Evidence Generation and Knowledge Brokering Unit (formerly 
ADRU) of the Health Research Board, providing advice, coordinating research efforts 
and maximising the use of resources;  
 Support the establishment of a National Documentation Centre;  
 Liaise with the relevant agencies nationally in order to co-ordinate research and 
resources;  
 Ensure participation nationally of a broad range of parties in fulfilling its research needs 
and dissemination of findings;  
 Serve all drug misuse reduction activities in providing for an effective dissemination of 
research findings, information and other data thus linking research to practice.  
Values 
The NACD agreed that the following values would guide the implementation of its work 
programme. The NACD will: 
 Manage the diversity of its membership and commit to a consensus approach in 
decision-making; 
 Foster a culture of respect, dignity, transparency and fairness in all its operations;  
 Advocate dialogue as a means of balancing the diverse views on and experiences of drug 
misuse in Ireland ; 
 Be objective in the collection and dissemination of information in line with its 
commitment to the National Drugs Strategy (NDS) 2001-2008, and subsequently 2009-
2016 Interim NDS ; 
 Commit to the highest possible standards of excellence and ethical conduct;  
 Seek out collaborations and partnerships where there is greater benefit to achieving its 
goal and co-operate with everyone who can benefit from its knowledge base. 
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CHAIRPERSON’S REPORT 
 
The past year has been a busy year for the NACD even though we published just 
one report during 2010. Much of our work involved preparation for the 2010/11 
General Population Survey on Drug Use, fieldwork for which started in October. 
We expect to be able to present the first findings from this third survey towards 
the end of 2011. Another area of intense activity was generated by the public 
controversy surrounding the so-called ‚Headshops‛ and the New Psychoactive 
Substances (NPAS) being offered for sale by these outlets. At the request of Mr. 
John Curran TD, the then Minister of State with responsibility for the National 
Drugs Strategy, the NACD established a multidisciplinary Research Advisory 
Group (RAG) which involved key stakeholders, to assist in developing advice 
and research into the challenges posed by these NPAS. The NACD subsequently 
commissioned a group of researchers at Dublin Institute of Technology (DIT) to 
undertake an in-depth analysis and review of the phenomenon. Their report is 
being prepared for publication at this point in time. I would like to record my 
thanks and that of the NACD to the DIT team and also to those who so willingly 
gave of their time and expertise to work on the RAG. 
 
During 2010 work also began on a major study of drug use in Irish prisons with a 
particular emphasis on the prevalence of injecting drug use and blood-borne 
viruses (HIV and Hepatitis C). This study has been made possible by co-funding 
from the Irish Prison Service and from the Office of the Minister for Drugs 
(OMD) on top of an allocation from the NACD budget. We are grateful to both 
the Irish Prison Service and the OMD for their support of this project. Work also 
commenced on alternative methods of estimating prevalence of opiate and 
cocaine use and on the design of a major study of rehabilitation outcomes. 
 
I am delighted to report that the NACD was able to recruit a Senior Researcher, 
Dr Justine Horgan, in September. The NACD welcomes this key appointment 
and we are grateful to all those in the OMD, Department of Community, 
Equality and Gaeltacht Affairs and the Health Research Board who helped bring 
about this appointment. Dr Horgan had previously worked for the NACD in 
developing the study of drug use in early school-leavers and in November she 
helped with the subsequent launch of the Report on Risk and Protection Factors for 
Substance Use Among Young People. The publication of that detailed report was 
quickly followed by a hugely successful seminar/workshop on its contents for 
stakeholders. 
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The varied and extensive work of the Committee would not be possible without 
the expertise and commitment of those who serve on the NACD, its sub-
committees and research advisory groups. Members continue to give unselfishly 
of their time and knowledge and they represent a unique national resource 
which should not be lightly discarded at the present time. I am deeply indebted 
to all of them for their contributions to the success of the NACD to date. 
 
As in previous years I want to record my appreciation of the support I have 
received from the Vice-Chair, Dr Mary Ellen McCann and to thank Mr. Liam 
O’Brien, Dr Eamon Keenan who chair the Consequences and 
Treatment/Rehabilitation Sub-committees respectively and also Ms Marita 
Kinsella, Chief Pharmacist at the Department of Health and Children who chairs 
the Early Warning and Emerging Trends Sub-committee. 
 
My colleagues and I are deeply indebted to the staff of the NACD, Alan Gaffney 
and Mary Jane Trimble who work extremely hard to ensure that the outputs of 
the Committee are timely and of the highest quality. I also want to pay a special 
tribute to the interim Director, Ms Susan Scally for all her hard work for the 
NACD over the past two difficult years. My colleagues and I have been 
impressed by her ability to brief herself on the detail of the NACD procedures 
and its Work Programme and to add real value to our discussions. Her 
unflagging energy and good humour has been an example to us all. It was 
reassuring for me as Chairperson to have another Director on whom I could rely 
totally. 
 
The continued support of the Minister and his officials in the OMD, for the work 
of the NACD, is welcome and has been an ever-present ingredient in the success 
of the Committee since its establishment in July 2000.  
 
 
Dr Des Corrigan FPSI 
Chairperson. 
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EXECUTIVE SUMMARY 
 
2010 was an eventful year for the NACD, marked by many challenges, not least 
responding to the threat of new and emerging psychoactive substances available 
through Head Shop outlets. In January 2010, at the request of the Minister with 
responsibility for the National Drugs Strategy, an expert and multi-disciplinary 
Research Advisory Group(RAG) was established by the NACD to carry out a 
review of new psychoactive substances and the outlets supplying them.  On foot 
of the deliberations of the RAG, the NACD advised Government in February 
2010 to bring a range of synthetic drugs under the control of the Misuse of Drugs 
Act.   On the basis of the findings of the review, the NACD agreed final 
recommendations designed to address the harms of psychoactive substances 
which were subsequently submitted to the Oversight Forum on Drugs.  
 
During 2010, six full Committee meetings, 15 sub-committee meetings and 31 
Research Advisory Group meetings were held. The new NACD work 
programme was substantially progressed during the year. The NACD 
commissioned new research into the optimum methods of generating estimates 
of heroin and cocaine prevalence and a study to design a protocol to measure 
rehabilitation outcomes.  In terms of in-house research, a review of literature on 
children of drug misusers was initiated which focuses on the impact of parental 
misuse on children’s lives. Most notably, the All Ireland Drug Prevalence Survey 
2010-2011 got underway in October. This is the third such survey on drug use in 
the general population carried out by the NACD, in collaboration with the Public 
Health Information and Research Branch at the Department of Health, Social 
Services and Public Safety, Northern Ireland.  
 
A major highlight of the year was the publication of the report on ‚Risk and 
Protection Factors for Substance Use among Young People‛.  Drawing on data 
collected in a survey of young people in 2008, the report explored the factors 
associated with substance use amongst those who left school early. The report 
found that both the family and experience of school can have a major impact on a 
young person’s decision to use substances.  The NACD organised a seminar in 
October 2010 to discuss the implications of the report with those involved in 
education provision and services for young people.  
 
We are very lucky at the NACD to have a small but highly effective secretariat. I 
am immensely grateful to Alan Gaffney, the NACD Office Manager and to Mary 
Jane Trimble who provides reception and secretarial support to the NACD, for 
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their hard work during the year.  I am also delighted to welcome Dr. Justine 
Horgan, Senior Researcher, to the team.  As this is my last year with the NACD, I 
would also like to take the opportunity to thank the Committee members for 
their support and most especially, Dr. Des Corrigan, who has been a great  
mentor during my period as interim director.  
 
Susan Scally 
Director 
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GLOSSARY OF TERMS 
 
 
 
C&AG    Comptroller and Auditor General 
 
DAG    Drugs Advisory Group 
 
DTMS    Drug Trend Monitoring System 
 
DIT    Dublin Institute of Technology 
 
ED    Electoral Division 
 
EGKBU   Evidence Generation and Knowledge Brokering Unit  
    (formerly ADRU) 
  
FOI    Freedom of Information 
 
HIV    Human Immunodeficiency Virus 
 
HRB    Health Research Board 
 
HSE    Health Service Executive 
 
IAAAC Irish Association of Alcohol and Addiction Counsellors 
 
LDTF Local Drugs Task Force 
 
MQI Merchants Quay Ireland 
 
NACD National Advisory Committee on Drugs 
 
NHISU National Health Information Systems Unit 
 
NVDS National Voluntary Drug Sector 
 
NDS National Drugs Strategy 
 
NUI National University of Ireland 
 
OFD Oversight Forum on Drugs 
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OJEU Official Journal of the European Union 
 
OMD Office of the Minister for Drugs 
 
PHIRB Public Health Information and Research Branch 
 
PQ Parliamentary Question 
 
RAG Research Advisory Group 
 
RDTF Regional Drugs Task Force 
 
RIWG Research and Information Working Group 
 
UCD University College Dublin 
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Chapter One 
 
Background and Functions of the NACD 
 
1.1 Origins 
 
The NACD was established in July 2000 to advise the Government on problem 
drug use in Ireland in relation to consequences, prevalence, prevention, and 
treatment including rehabilitation, based on its analysis and interpretation of 
research findings and information available to it.  It also provides ‘early warning’ 
advice to Government. The Committee comprises representation from 
Government Departments, Academia, Community, Voluntary and Statutory 
sectors and reports to the Minister with responsibility for the National Drugs 
Strategy. Further information can be obtained from the website www.nacd.ie. 
 
Arising from a Government decision to renew the NACD mandate in 2004, a 
further work programme was developed. A consultation process was 
undertaken with key interest groups and stakeholders to explore further research 
and information opportunities. The business plan developed incorporates the 
continuation of the programme and identifies ongoing gaps in knowledge.   
 
Further to Government approval during 2009 of proposals for a new National 
Drugs Strategy (interim) 2009-2016, the NACD mandate was extended until the 
end of 2011 and work began on developing a new work programme. This 
involved a consultation process with members of the five sub-committees of the 
NACD. The key priorities of the work programme for 2010-2011 were 
determined at a planning session of the NACD in November 2009. The work 
programme was agreed by the Minister with responsibility for the Drugs 
Strategy, the Office of the Minister for Drugs and the NACD in December 2009.  
 
Over the years the NACD has worked closely with other agencies and 
organisations to optimise skills and resources in gathering information and 
filling gaps in knowledge.  The NACD works with the Health Research Board’s 
Evidence Generation and Knowledge Brokering Unit on meeting the information 
needs of the EU Five Key Indicators of Drug Use.  The NACD is engaged in 
ongoing collaborative work with colleagues in the Public Health Information and 
Research Branch of the Department of Health, Social Services and Public Safety 
in Northern Ireland, gathering information on drug prevalence amongst the 
general population on the whole island. 
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The work programme and modus operandi of the NACD is an evolving process 
and further information can be obtained on the NACD website.  However, its 
core functions were set down by Government in 2000 and these have not altered. 
 
1.2 Functions 
 
On its establishment in 2000, the functions of the NACD (the Committee)  were 
set out as follows: 
 
 Based on the Committee’s analysis and interpretation of research findings 
and information available to it, to advise the Cabinet Committee on Social 
Inclusion and, through it, the Government, in relation to the prevalence, 
prevention, treatment and consequences of problem drug use in Ireland; 
 To review current information sets and research capacity in relation to the 
prevalence, prevention, treatment and consequences of problem drug use 
in Ireland and to make recommendations, as appropriate, on how deficits 
should be addressed including how to maximise the use of information 
available from the community and voluntary sector; 
 To oversee the delivery of a prioritised programme of research and 
evaluation as recommended by the Interim Advisory Committee to meet 
the gaps and priority needs identified; by: 
 
a)  using the capacity of relevant agencies engaged in information 
gathering and research, both statutory and non-statutory, to deliver 
on elements of the programme; 
b)  liaising with these agencies with a view to maximising the resources 
allocated to delivering the programme and avoiding duplication; 
c)  coordinating and advising on research projects in the light of the 
prioritised programme; 
d)  commissioning research projects which cannot be met through 
existing capacity; 
e)  commissioning additional research at the request of the Government 
into drug issues of relevance to policy. 
 
 To work closely with the Health Research Board (HRB) on the 
establishment of a national information/research database (in relation to 
the prevalence, prevention, treatment and consequences of problem drug 
use) which is easily accessible; and 
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 To advise relevant Agencies with a remit to promote greater public 
awareness of the issues arising in relation to problem drug use and to 
promote and encourage debate through the dissemination of its research 
findings.  
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Chapter Two 
 
Structures and Work Programme 
 
2.1 Structures  
 
2.1.1 The NACD 
 
The NACD comprises 19 members who, with the exception of the Chairperson, 
participate on a voluntary basis.  Since 2005, the Chairperson receives a small 
honorarium. Members serve at the invitation of the Minister and their 
participation requires them to sit on the NACD main committee and at least one 
sub-committee.  NACD meetings are generally scheduled to take place every six 
weeks excluding July and August.  In 2010, there were six meetings held. Full 
membership is detailed in Appendix 1. 
 
2.1.2 Sub-Committees 
 
Due to the complexity of the drugs issue the NACD manages its work 
programme through sub-committee structures including research advisory 
groups (RAGs).  There are five sub-committees in operation: Consequences; 
Early Warning Emerging Trends (EWET); Prevalence; Prevention; and 
Treatment/Rehabilitation.  Each committee meets as required and according to 
the needs of the NACD work programme.  In 2010, a total of 15 sub-committee 
meetings were held as follows: Consequences (1); Early Warning Emerging 
Trends (4); Prevalence (4); Prevention (4); and Treatment/Rehabilitation (2). 
There were a total of 31 RAG meetings in 2010.  A special meeting of the 
laboratory stakeholders on the EWET Sub-committee was also held to explore 
how NDS Action 54 might be advanced. 
 
Full sub-committee membership is detailed in Appendix 2. 
 
2.1.3 Terms of Reference 
 
Terms of Reference for sub-committees and research advisory groups are 
available on the NACD website. 
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2.2 Work Programme of NACD 
 
The National Drugs Strategy (interim) 2009-2016 details the actions for which the 
NACD has lead responsibility. These actions are set out in Appendix 3 of this 
report and further information is available on the website of the Office of the 
Minister for Drugs www.pobail.ie. In light of the research and information 
priorities identified in the Strategy, the development of a new NACD work 
programme to cover the period up to 2011 was advanced in the latter part of 
2009.    
 
In 2010, there were five new research projects externally commissioned, one new 
internal research project and three ongoing research projects carried over from 
the previous year. 
 
2.2.1 Summary of 2010 
 
The ongoing work programme included the following projects: 
 
 Finalising the study on the comparison of risk and protection factors for 
drug use amongst early school-leavers and  school-attendees ;  
 Research into drug markets in Ireland; 
 Planning for the 2010-2011 Drug Prevalence Survey; 
 
Internal research: 
 
 Review of the literature on Children of Drug Users. 
 
Externally commissioned research: 
 
 An Overview of New Psychoactive Substances and the Outlets Supplying 
them; 
 General Population Survey on the Prevalence of Drug Use in Ireland and 
Northern Ireland 2010/2011; 
 Design of the Protocol for National Substance Misuse Rehabilitation 
Cohort Study; 
 Identify Methods and Data Sources for the Estimation of Prevalence of 
Problematic Opiate and Cocaine Use in Ireland; 
 The Prevalence of Drug Use Including Intravenous Drug Use, and Blood 
Borne Viruses among the Irish Prisoner Population. 
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Internal work – summary of activities: 
 
 A report of the study to compare the risk and protection factors for drug 
use amongst early school-leavers and  school-attendees–  editing, 
proofing, tender issue/evaluation for design and print, launch and 
distribution; 
 Organisation of a Seminar for over 100 stakeholders to discuss the 
findings and policy implications of the NACD study on the comparison of 
risk and protection factors for drug use amongst early school-leavers and  
school-attendees; 
 Drug Markets Study –  ongoing monitoring and support; 
 Tender issue/evaluation and contract drafting for all commissioned 
research; 
 Feedback to the Oversight Forum on Drugs;  
 Preparation of  the 2009 Annual Report for publication on the web; 
 Maintenance of the website and ongoing Irish translation of relevant 
uploads to website; 
 Preparatory work on Population Survey 2010/2011 
 Provision of secretariat support to NACD, sub- committees and RAGs ; 
 Office management and financial reporting. 
   
  
2.2.2 The Research Process 
 
All research has the support of a Research Advisory Group (RAG).  The Terms of 
Reference for these RAGs have been noted in previous reports and are now 
available on the website. The RAG comes together once the research question has 
been decided by the relevant sub-committee and then the commissioning process 
for implementing the research study can begin.  Research can be externally 
contracted via requests for tenders, direct engagement or conducted internally by 
the NACD Senior Researcher. The RAG, which generally comprises relevant 
stakeholders and/or experts, reviews the research, supports the researchers, 
advises and guides when appropriate and reviews written output. The RAG then 
passes the report on to the relevant sub-committee along with suggested 
recommendations arising from the research. The sub-committee will then review 
the report and agree recommendations for consideration and final approval by 
the NACD. 
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2.2.3 Commissioned Research 
 
Five research projects were commissioned in 2010, as outlined below: 
 
(i)An Overview of New Psychoactive Substances and the Outlets 
Supplying Them 
 
Article 14 of the National Drugs Strategy (interim) 2009-2016, provides for 
the monitoring of activities of ‘Head shops’ and all businesses involved in 
the sale of psychoactive substances to ensure no illegal activity, and to 
highlight gaps in our knowledge about these substances and their supply. 
 
Following a competitive tendering process, Dublin Institute of Technology 
were commissioned in May 2010 to review the psychoactive substances 
sold in ‘Head shops’ and other outlets including internet sites.  The 
researchers were required to carry out an analysis of the substances 
contained in the products and compare them with the contents as stated 
on the labels.  They were also asked to gather information on the user’s 
experiences of the substances, and the psychoactive effects on cognition, 
mood, mental health and dependence. 
 
A better understanding of the risk factors associated with the use of these 
products and suggested harm reduction measures to minimise the risk to 
users, together with information on the availability of new reference 
standards to facilitate the analysis of new psychoactive substances is 
helpful to fill knowledge gaps in this area.  The final report is due in 2011. 
 
(ii) Drug Use in Ireland and Northern Ireland 2010/2011 Drug  
 Prevalence Survey 
 
Further to the planning and preliminary work that started in 2009, work in 
2010 concentrated on finalising the questionnaire, the tender, and the 
commissioning process for this, third all Island population survey. 
 
The 2010/2011 survey of Drug Use in Ireland and Northern Ireland is 
broadly similar to the 2006/2007 survey, but contains additional questions 
designed to estimate the prevalence of alcohol and cannabis dependence 
in the general population.  Care has been taken to ensure that 
comparisons can be made with the previous two surveys carried out in 
02/02 and 06/07. 
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The 2010/2011 Drug Prevalence Survey is being carried out according to 
standards set by the EMCDDA.  The fieldwork, which is being undertaken 
by Ipsos MORI, started in October 2010 and is expected to finish in 2011.  
A series of NACD bulletins arising from the survey will be published in 
2011/2012.  
 
(iii)Design of Protocol for National Substance Misuse Rehabilitation 
Cohort Study 
 
The University of Glasgow were  awarded the contract to design a 
national cohort study protocol, to measure the rehabilitation outcomes for 
people with substance misuse problems who have availed of 
rehabilitation services in Ireland.  The study will provide information on 
the effectiveness of the different models based on rehabilitation outcomes 
for the participants of the study. 
 
The aim of this study is to provide evidence based recommendations to 
policy makers and service providers, define, derive and measure a set of 
rehabilitation outcomes for problem drug and alcohol users in Ireland, 
and to provide an understanding of progression pathways to employment 
for recovering users.  Expected to report in early 2011. 
 
(iv)Methods and Data Sources for the Estimation of the Prevalence of 
Problematic Opiate and Cocaine Use in Ireland 
 
The University of Glasgow was commissioned to determine statistical 
approaches to estimate the prevalence of problematic opiate and cocaine 
use in Ireland.  This study will help to identify statistical and practical 
adaptations to improve the reliability of the estimate generated by the 
capture/recapture method.  The study will identify all the data sources in 
Ireland that could be used to estimate the prevalence of problematic 
cocaine and opiate use and will apply a systematic approach to evaluating 
the usefulness of these methods.  The researchers will design a pilot study 
to test the preferred approaches and methods.  Work started in September 
2010 with the final report due in early 2011. 
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(v) The Prevalence of Drug Use, including Intravenous Drug Use, and 
Blood Borne Viruses among the Irish Prisoner Population 
 
University College Dublin has been commissioned to carry out a study to 
determine the need for drug treatments and harm reduction (including 
needle exchange) services in Irish prisons.The study will describe the 
nature, extent and pattern of consumption for different drugs, and the 
methods, including intravenous, of drug use among the prison 
population.  The study will also provide an estimate of the prevalence of 
blood borne viruses, identify associated risk behaviours among the prison 
population and measure the uptake of individual drug treatment and 
harm reduction interventions (including hep B vaccination) in prison.  
Work started in November 2010 and the final report is due in December 
2011. 
 
2.2.4 Ongoing Research     
 
(i) Risk and Protection Factors for Substance use among Young People: 
A comparative study of early school-leavers and school-attending 
students 
 
The NACD acted as Principal Investigator in this internally designed 
study.  Ethical approval for the study was given by the Drug Treatment 
Centre Board Research Ethics Committee. The aim of this study is to 
examine drug use among early school-leavers and school-attendees in the 
context of risk and protective factors. Following completion of the pilot 
study, a tender issued for the fieldwork element of the main study and 
this was awarded to Ipsos MORI. Fieldwork was completed in 2008. 
Following an initial analysis of the survey data, completed in 2009, the 
NACD commissioned an external researcher to draft a report based on the 
results of the research.  This report, was finalised and published in 
October 2010 and the subject of a Seminar hosted by the NACD in 
November 2010. 
  
(ii)  Drug Markets Study 
 
The Health Research Board was commissioned to conduct a study on the 
illicit drug markets in Ireland in order to address a gap in available 
research in this area. The study is intended to examine the factors which 
can influence the development of local drug markets, the nature, 
  
 - 21 - 
organisation, and structure of Irish drug markets and the impact of drug 
dealing and drug markets on local communities. It is hoped that the 
research will assist in furthering the objectives and key performance 
indicators outlined under the supply reduction pillar of the National 
Drugs Strategy. Qualitative interviewing and analysis of data collated in 
relation to the research sites was completed during 2009.  As of the end of 
2010 the final report is being completed and is expected to go to the 
NACD for consideration in early 2011. 
 
2.2.5 Collaboration 
 
Collaborative working is a core principle of the NACD and every effort is made 
to involve stakeholders at various levels in relevant discussions, research projects 
and research activities.  Over the last year the NACD has been very active in 
collaborating with colleagues in Northern Ireland on the third All Ireland Drug 
Prevalence Survey.  In addition, the NACD convened relevant stakeholders in 
the various RAGs to support other research projects. They included 
representatives from: the Forensic Science Laboratory; Youthreach; State 
Laboratory; Beaumont Hospital; Drug Treatment Centre Board; Irish Medicines 
Board; The Health Research Board; Barnardos; Food Safety Authority of Ireland; 
Citywide; Merchants Quay Ireland; Coolmine; Irish Prison Service; Casadh; 
Dublin Aids Alliance; Ana Liffey Drug Project; Family Support Network; Health 
and Safety Authority; UCD; Trinity College; University of Glasgow; Dublin 
Institute of Technology; National Youth Council of Ireland; Crosscare Drug and 
Alcohol Programme; An Garda Síochána; Customs Drugs Law Enforcement Unit 
of The Revenue Commissioners; Departments of Education and Skills; Justice 
and Law Reform; Health and Children; The Health Service Executive; Office of 
the Minister for Children; and Office of the Minister for Drugs. 
 
2.3 Performance Management 
 
2.3.1 Staff  
 
The NACD has four core posts. The Director post has been filled on secondment 
from the Department of Community, Equality and Gaeltacht Affairs since 
February 2009, the Senior Researcher was contracted in September 2010 and a 
Higher Executive Officer and Clerical Officer are also on secondment from the 
Department of Community Equality and Gaeltacht Affairs. 
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2.3.2 Balanced Scorecard 
 
In 2010 the NACD had an efficiency rate of 84%. There were 20 internal meetings 
some of which were team meetings held to manage the flow of work and to 
maintain the high levels of productivity from such a small team.  The remaining 
meetings related to the work of sub-committees, RAGs and visitors to the 
NACD.  
 
Ministerial Briefings, advice to Government and information relating to 
Parliamentary Questions were provided on 20 occasions.   There were 15 external 
meetings, relating to the provision of support to other agencies and to the 
research programme of the NACD.  The NACD was also represented at meetings 
of the Oversight Forum on Drugs (OFD) and other fora on five occasions. 
 
In addition to commissioning and managing research, the work programme 
generates a range of other activities which adds another project management 
dimension to the operations of the NACD.  Internal work includes providing 
secretariat support to the various committees, organising events, media relations 
and managing the publication process (which involves proofing, editing, 
checking in great detail all drafts going to and coming from the design house and 
co-ordinating the printing process). Each publication generates a series of 
activities related to planning and organising the dissemination of reports, to key 
stakeholders.   
 
2.3.3. Freedom of Information (FOI) 
 
The NACD makes most of its information available on-line. Nonetheless, it 
receives FOI requests from time to time. A reference book has been published on 
the website in accordance with the requirements of Sections 15 and 16 of the FOI 
Acts. In accordance with Section 15 of the Act, the purpose of this reference book 
is to facilitate access to official information held by the NACD, by outlining the 
structure, functions and details of the services provided by the NACD, how they 
may be availed of, information on the classes of records held, and information on 
how to make a request to the NACD under the Freedom of Information Acts, 
1997 and 2003. Section 16 of the FOI Act requires the NACD to publish a book 
containing the rules, procedures, practices, guidelines and interpretations used 
by the NACD. Copies of this publication are available at www.nacd.ie and upon 
request from the offices of the NACD. 
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The FOI Officer at the NACD is Mary Jane Trimble. Alan Gaffney is the FOI 
Decision Maker and internal appeals are dealt with by the Director.  There was 
one FOI request in 2010. 
 
2.3.4 Office of the Minister for Drugs (OMD) Support  
 
The NACD provided information in response to Parliamentary Questions (PQs) 
to the OMD, at the Department of Community, Equality & Gaeltacht Affairs and 
provided other information in response to general queries on drug issues 
throughout 2010. The OMD supported the NACD in the preparation and signing 
of contracts and in the administration of financial resources allocated to NACD.   
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Chapter Three 
 
Communications 
 
One of the core functions of the NACD requires a commitment to 
communications in its broadest sense to promote and encourage debate and 
discussion of drug issues internally and externally amongst the wide range of 
stakeholders who interact with it. The publication and distribution of NACD 
research is a further dimension to using communications tools to achieve goals.  
 
The objectives of the communications strategy are: 
 To provide timely advice and briefings to the Minister on key issues and 
emerging trends; 
 To advise service providers and practitioners across sectors  in relation to 
research findings that may inform current thinking and practice; 
 To promote the research agenda amongst key influencers in those 
agencies and bodies that promote, commission, fund or undertake drug-
related research and/or have access to relevant data in this field;  
 To represent the NACD and Ireland at international fora. 
3.1 Advice to Government 
 
The NACD provides ongoing advice to Government through its participation on 
the Oversight Forum on Drugs, in its briefings with the Minister and through 
recommendations made based on research or information it had considered.  The 
NACD also provides advice and support to the Office of the Minister for Drugs 
in responding to parliamentary questions and general queries relating to its 
work. 
 
3.2 Media Relations 
 
In October 2010 the NACD launched the report “Risk and Protective Factors for 
Substance Use Among Young People – A Comparative Study of Early School-Leaving 
and School-Attending Students ” via a media briefing and there was a broad range 
of media representatives in attendance. The author Mr Trutz Haase presented the 
report and Minister Pat Carey TD, the NACD Chairperson Dr Des Corrigan and 
other NACD members were on hand to give interviews on various issues arising 
from the research. 
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NACD publications generate good news coverage and although there was only 
one report launched in 2010, it was well covered by the media. Three daily 
newspapers published articles relating to the report; it was covered in news 
bulletins on 12 radio stations; on national television news bulletins; and also 
featured in many online news publications.  
 
3.3 NACD Website 
 
The website contains all the necessary information about the NACD, including 
its vision, mission, values, functions and membership. Information on the sub-
committee structure and the NACD’s programme of work is also included. 
 
The site was restructured to make it more user-friendly and has been updated to 
include the research projects, events and seminars which took place in 2010 and 
in previous years.  
 
All NACD reports are published simultaneously on the website and can be 
downloaded free of charge.  The website is in bilingual format - English and Irish 
- thus Irish versions of annual reports, business plans, press releases and research 
summaries dating from 2003 can be downloaded.  
 
3.4 Seminars /Conferences organised by NACD staff in 2010. 
 
NACD Conference ‚Responding to the Challenges of Substance Use Among 
Young People in Ireland‛ - Gresham Hotel, Dublin.   17th November 2010 
 
Following on from the media launch of the report “Risk and Protective Factors 
for Substance Use Among Young People- A Comparative Study of Early School-
Leaves and School-Attending Students‛ the Prevention Sub-committee decided 
that a half day seminar would provide an opportunity for stakeholders from the 
State, Community and Voluntary sectors to discuss the findings of this research. 
 
Over 100 people, from a very wide range of agencies attended the seminar.   
There were four keynote speakers, Mr. Trutz Hasse and Dr Jonathan Pratschke 
presented the key findings of the research; Dr Bobby Smyth, Consultant Child 
and Adolescent Psychiatrist with the HSE, gave a talk on strategies to enhance 
resilience among Irish teenagers; and Mr Dermot Stokes, National Coordinator 
for Youthreach spoke about the risk and protective factors in young people’s use 
of alcohol and drugs from an education perspective. 
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Those in attendance were then given time to discuss the themes emerging from 
the research in a group setting and the seminar concluded with a lively questions 
and answers session.  
 
3.4.1   Seminars /Conferences attended by NACD staff in 2010 
 
Head shops - Risk Assessment of the ‘Legal Highs’ 
Mullingar, 26 January 2010  
 
Irish National Drugs Conference 2010 
Dublin, 4-5 November 2010  
 
 
3.5 Publications by NACD in 2010 
 
NACD Annual Report 2009. Published on the web only in June 2010 
 
Risk and Protective Factors for Substance Use Among Young People: A 
Comparative Study of Early School-Leavers and School-Attending 
Students.  Published in October 2010 
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Chapter Four 
 
Finance  
 
4.1   Research – Funding Allocations 
(for Research Projects Commissioned in 2010) 
(includes VAT where applicable) 
 
Prevalence 
 
General Population Survey of Drug Use 2010/2011 
Ipsos MORI               €689,700 
 
Study on the Prevalence of Drug Use, including Intravenous Drug Use, 
and Blood Borne Viruses among the Irish Prisoner Population 
University College Dublin       €289,647 
The Irish Prison service contributed €80,000 towards the total cost of the  
Study. 
 
Study on Alternative Methods and Data Sources for Estimating Prevalence of 
Problematic Opiate and Cocaine Use in Ireland 
University of Glasgow          €24,152 
 
Treatment/Rehabilitation  
 
Design of a Protocol for a National Substance Misuse Rehabilitation 
Cohort Study 
University of Glasgow    €29,606 
 
Research Advisory Groups 
 
An Overview of New Psychoactive Substances and the Outlets Supplying 
Them 
Dublin Institute of Technology €25,350 
                          
 
Total NACD Allocation  €1,058,455 
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4.2 NACD Expenditure 
 
An annual budget of €700,000 was allocated by the Department of Community, 
Equality and Gaeltacht Affairs towards the operation of the NACD. Seventy per 
cent of the annual budget is allocated to research funding and the remaining 30% 
to general administration. 
 
The figures presented are a description of NACD expenditure on research and 
general administration for 2010.  NACD finance is integrated within the general 
accounts of the Department of Community, Equality and Gaeltacht Affairs. 
 
NACD expenditure on new and existing research projects, including media 
relations, for 2010 €554,773.13 
 
NACD expenditure on general administration, including pay and legal services, 
for 2010           €150,425.69 
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Appendix One 
 
Membership of NACD Committee at 31st December 2010 
 
Chairperson 
Dr Des Corrigan, Visiting Academic, School of Pharmacy and 
Pharmaceutical Sciences, Trinity College 
 
Vice-Chairperson  
Dr Mary Ellen McCann, Academic Appointment 
 
Members 
Prof Joe Barry, Academic Appointment 
Mr Denis Bradley, National Voluntary Drugs Sector 
Mr Declan Byrne, Community Sector 
Mr Michael Conroy, Dept. of Community, Equality & Gaeltacht Affairs 
Senator Maria Corrigan, Clinical Psychologist 
Mr Joseph Doyle, National Drug Rehabilitation Implementation 
Committee  
Mr Tony Duffin, National Voluntary Drug Sector 
  Mr Bill Ebbitt, HSE Health Promotion Directorate 
Ms Deirdre Meenan, Dept. of Justice & Law Reform 
Dr Eamon Keenan, Consultant Psychiatrist, HSE South Western Area   
Dr Jean Long, EGKBU, Health Research Board 
Ms Geraldine Luddy, Dept. of Health & Children 
Mr Charles R. Murphy, IAAAC 
Mr Liam O’Brien, Community Sector 
Dr Máirín O’Sullivan, Dept. of Education & Skills  
Det. Supt Michael D. O’Sullivan, Garda National Drugs Unit 
Ms Fiona Walsh, HSE Western Area 
 
Retired NACD Members (2010) 
Mr Tony Barden, HSE South East  
Mr John Garry, Dept. of Justice & Law Reform  
 
Members of Sub-committees (during 2010) 
(Not sitting on Main Committee) 
 
Consequences 
Mr Stephen Bartley, Dept. of Community, Equality & Gaeltacht Affairs 
Dr Suzi Lyons, NHISU, Health Research Board 
Ms Mary O’Shea, Dublin Aids Alliance 
Dr Cathal O’Sullivan, HSE 
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Ms Alison Reilly, Dept. of Justice & Law Reform 
Mr Gabriel Staunton, Dept. of Community, Equality & Gaeltacht Affairs 
 
Early Warning/Emerging Trends 
Ms Marita Kinsella, Dept. of Health & Children 
Ms Niamh Arthur, Irish Medicines Board 
Mr Stephen Bartley, Dept. of Community, Equality & Gaeltacht Affairs 
Ms Helen Crosse, Toxicology Department, Beaumont Hospital 
Dr James Gray, Emergency Dept. AMNCH 
Mr Gerry Hayes, Dept. of Justice & Law Reform 
Ms Jelena Ivanovic, Crosscare Drug & Alcohol Programme  
Dr Pierce Kavanagh, Trinity Centre for Health Sciences  
Dr Richie Maguire, Medical Bureau of Road Safety  
Ms Peggy McGlynn, Forensic Science Laboratory  
Mr Barry McGreal, Dept. of Justice & Law Reform 
Mr Chris Murphy, Crosscare Drug & Alcohol Programme 
Ms Lorraine Nolan, Irish Medicines Board  
  Dr Audrey O’Donnell, Forensic Science Laboratory 
Dr Dan O’ Driscoll, Forensic Science Laboratory 
Ms Mary O’Reilly, Dept. of Health & Children 
  Ms Noreen Quinn, Dept. of Health & Children 
Mr Liam Regan, State Laboratory  
Det Sergeant Brian Roberts, Garda National Drugs Unit  
  Ms Maria Ryan, Revenue Commissioners    
Dr Bobby Smyth, HSE South Western Area 
Mr Gabriel Staunton, Dept. of Community, Equality & Gaeltacht Affairs  
Ms Siobhan Stokes, Drug Treatment Centre Board   
Ms Gillian Treacy, Dept. of Health & Children   
Dr Joe Tracey, Toxicology Department, Beaumont Hospital 
Ms Fiona Walsh, HSE Western Area 
 
Prevalence  
Mr Eddie Arthurs, Dept. of Community, Equality & Gaeltacht Affairs 
Mr Barry McGreal, Dept. of Justice & Law Reform 
Dr Bobby Smyth, HSE South Western Area 
 
Prevention 
Mr Robbie Breen, Dept. of Health & Children 
Mr Pat Hanna, Rehabilitation and Support Programme (RASP)  
Ms Mary Johnston, Walk Tall Programme Support Services 
Ms Ger McHugh, National Youth Council of Ireland  
Ms Ruby Morrow, Church of Ireland College of Education 
Ms Dairearca Ní Néill, Dept. of Community, Equality & Gaeltacht Affairs  
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Ms Clare O’Reilly, Dept. of Health & Children 
Ms Mary O’Shea, Dublin Aids Alliance 
Mr Conor Rowley, Office of the Minister for Children & Youth Affairs 
(OMCYA) 
 
Treatment / Rehabilitation 
Mr Alan Bell, Dept. of Health & Children 
Ms Elaine Butler, Homeless Agency   
Mr Paul Conlon, Coolmine Therapeutic Community 
Ms Miriam Conway, FÁS Community Services 
Ms Frances Nangle-Connor, Irish Prison Service 
Mr Seamus Hempenstall, Dept. of Education & Skills 
Dr Suzi Lyons, NHISU, Health Research Board 
Ms Siobhan Maher, Family Support Network  
Mr Tim McCarthy, Dept. of Health & Children 
Ms Dairearca Ní Néill, Dept. of Community, Equality & Gaeltacht Affairs 
Mr Brendan Ryan, Dept. of Health & Children  
Ms Elizabeth Toal, Homeless Agency 
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Appendix Two 
 
Table of Sub-Committee Membership at 31st December 2010 
 
    Consequences EWET Prevalence Prevention Treatment 
Dr Des Corrigan 
Visiting Academic, School of 
Pharmacy and Pharmaceutical 
Sciences, Trinity College 
     
Dr Mary Ellen 
McCann 
Academic Appointment      
Prof Joe Barry  Academic Appointment      
Mr Bill Ebbitt Health Service Executive      
Senator Maria 
Corrigan  
Clinical Psychologist      
Mr Declan 
Byrne 
Community Sector      
Mr Tony Duffin National Voluntary Drug Sector      
Dr Eamon 
Keenan 
Consultant Psychiatrist, HSE 
South Western Area   
    
Dr Jean Long EGKBU, Health Research Board      
Ms Geraldine 
Luddy 
Department of Health and 
Children 
     
Mr Joseph 
Doyle 
National Drug Rehabilitation 
Implementation Committee  
         
Det Supt 
Michael 
D.O’Sullivan 
 
Garda National Drugs Unit      
Mr Liam 
O'Brien 
Community Sector           
Ms Fiona Walsh HSE South East Region           
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    Consequences EWET Prevalence Prevention Treatment 
Mr Charles R. 
Murphy 
IAAAC      
Dr Máirín 
O'Sullivan 
Department of Education and 
Skills 
     
Ms Alison Reilly 
Department of Justice and Law 
Reform  
    
Ms Mary O’Shea Dublin Aids Alliance      
Dr Suzi Lyons NHISU, Health Research Board      
Dr Cathal 
O’Sullivan 
HSE      
Mr Stephen 
Bartley 
Department of Community 
Equality and Gaeltacht Affairs   
   
Ms Marita 
Kinsella 
Chief Pharmacist, Department of 
Health and Children 
 
 
   
Dr Joe Tracey 
Toxicology Department 
Beaumont Hospital 
     
Ms Peggy 
McGlynn 
Forensic Science Laboratory      
Dr James Gray 
Emergency Department 
AMNCH 
     
Ms Gillian 
Treacy 
Department of Health and 
Children 
 
 
   
Mr Gerry Hayes 
Department of Justice and Law 
Reform 
     
Det Sergeant 
Brian Roberts 
Garda National Drugs Unit      
Ms Mary 
O’Reilly 
Department of Health and 
Children 
     
Mr Liam Regan State Laboratory      
Dr Daniel 
O'Driscoll 
Forensic Science Laboratory      
Ms Noreen 
Quinn 
Department of Health and 
Children 
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    Consequences EWET Prevalence Prevention Treatment 
Ms Helen 
Crosse 
Toxicology Department 
Beaumont Hospital 
     
Dr Bobby Smyth HSE, South Western Area      
Dr Richie 
Maguire 
Medical Bureau of Road Safety  
 
   
Ms Maria Ryan Revenue Commissioners  
 
   
Ms Lorraine 
Nolan 
 
Irish Medicines Board  
 
   
Dr Pierce 
Kavanagh 
Trinity Centre for Health 
Sciences 
 
 
   
Ms Siobhan 
Stokes 
Drug Treatment Centre Board  
 
  
 
 
 
Mr Chris 
Murphy 
Crosscare Drug and Alcohol 
Programme 
 
 
   
Ms Jelena 
Ivanovic 
Crosscare Drug and Alcohol 
Programme 
 
 
   
Mr Barry 
McGreal 
Department of Justice and Law 
Reform 
 
     
  
Mr Eddie 
Arthurs 
Department of Community, 
Equality and Gaeltacht Affairs 
  
   
  
Mr Robbie 
Breen 
Department of Health and 
Children 
   
 
 
Ms Ruby 
Morrow 
Church of Ireland College of 
Education 
   
 
 
Ms Mary 
Johnston 
Walk Tall Programme Support 
Services 
   
 
 
Ms Clare 
O’Reilly 
Department of Health and 
Children 
     
Mr Conor 
Rowley 
Office of the Minister for 
Children & Youth Affairs 
       
 
Ms Ger 
McHugh 
National Youth Council of 
Ireland 
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    Consequences EWET Prevalence Prevention Treatment 
Mr Pat Hanna 
Rehabilitation and Support 
Programme (RASP 
        
 
Ms Dairearca Ní 
Néill 
Department of Community 
Equality and Gaeltacht Affairs 
     
Ms Frances 
Nangle-Connor 
Irish Prison Service     
 
Mr Alan Bell 
Department of Health and 
Children 
    
 
Mr Paul Conlon 
Coolmine Therapeutic 
Community 
    
 
Mr Seamus 
Hempenstall 
Department of Education and 
Skills 
     
 
Mr Brendan 
Ryan 
Department of Health and 
Children 
    
 
 
 
Ms Elaine Butler The Homeless Agency     
 
Ms Miriam 
Conway 
FÁS Community Services     
 
Ms Siobhan 
Maher 
Family Support Network     
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Appendix Three 
Actions required of the NACD under the National Drugs Strategy 
(interim) 2009-2016  
 
49 Continue to implement and develop, as appropriate, the five key   
 EMCDDA epidemiological indicators and the associated collection 
 systems; 
(i) Prevalence and patterns of drug use among the general population; 
(ii)Prevalence and patterns of problem drug use. 
 
54 Consider the further development of systems monitoring changing drugs 
trends in line with the EU Early Warning System 
 
55 The Minister of State, the OMD and the NACD will develop and prioritise 
a research programme, revised on an annual basis.  This would consider 
the following areas among others for possible research; 
 Areas of research recommended in the report of the Working 
Group on Drugs Rehabilitation; 
 Harm reduction approaches, based on an evidence-based approach 
covering developments internationally; 
 Examining the evidence of the effectiveness of the progression of 
clients from substitute maintenance treatments to abstinence; 
 Psychosocial adjustment, and quality of life, of patients on long-
term methadone maintenance treatment; 
 Examining the misuse and prolonged use of psychotropic drugs; 
 Factors influencing deaths that are indirectly related to drugs; 
 New developments in treatments for drugs; 
 The  impact of alcohol and drugs on the Irish health and justice 
systems; 
 Further research on psychiatric co-morbidity among drug users; 
 Prevalence patterns of problem substance use among prisoners and 
homeless people; and 
 Examining the feasibility of developing an indicator to monitor 
changes in the prevalence of substance misuse among youth at risk 
 
 56  Develop a research management framework in regard to problem   
  substance use in Ireland.  Disseminate research findings and models of  
  best practice.  
